10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

ABBOTT LABORATORIES

Ticker: ABT   Fiscal Year: 2011

Consolidated Statement of Earnings

Period Ending Dec 31, 2011 10-K (Filed: Feb 21, 2012)

(In Millions, except shares in Thousands)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2011Dec 31, 2010Dec 31, 2009
Net Sales
$
38,851
35,16730,765
Cost of products sold15,54114,66513,209
Research and development4,1293,7242,744
Acquired in process and collaborations research and development672313170
Selling, general and administrative12,75710,3768,406
Total Operating Cost and Expenses33,09929,07924,529
 
Operating Earnings5,7526,0886,236
 
Interest expense530553520
Interest (income)(85)(105)(138)
Net foreign exchange (gain) loss(50)(11)36
Other (income) expense, net159(62)(1,375)
Earnings Before Taxes5,1995,7137,194
 
Taxes on Earnings4701,0871,448
Net Earnings4,7284,6265,746
 
Basic Earnings Per Common Share (in dollars per share)3.032.983.71
Diluted Earnings Per Common Share (in dollars per share)3.012.963.69
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares)1,557,6431,546,4001,546,983
Dilutive Common Stock Options and Awards (in shares)9,7469,6228,143
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options and Awards (in shares)1,567,3891,556,0221,555,126
 
Outstanding Common Stock Options Having No Dilutive Effect (in shares)26,78929,40366,189
External Links 
ABBOTT LABORATORIES (ABT) Fiscal Year 2011
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip